Allergen-specific immunotherapy (AIT) is the only causal therapy with a proven long-term
benefit in allergic airway diseases, such as allergic bronchial asthma or allergic …

Background As in many fields of medical care, the coronavirus disease 2019 (COVID‐19)
resulted in an increased uncertainty regarding the safety of allergen immunotherapy (AIT) …

Background When the coronavirus pandemic 2019 (COVID‐19) emerged, concerns were
also raised regarding the safety of allergen immunotherapy (AIT). The German Society for …

Background: Vaccinations against severe acute respiratory syndrome coronavirus type 2
(SARS-CoV-2) are intended to induce an immune response to protect against …

The current COVID-19 pandemic influences many areas of social life, medical treatments
and the way allergy diagnosis and treatment is performed. Allergen-specific immunotherapy …

Pneumologists, Sleep and Respiratory Physicians (BdP)(Sebastian Böing), Professional
Association of German Dermatologists (BVDD)(Klaus Strömer) were taking part in the …

Background Allergen Immunotherapy (AIT) is broadly used all over the world as the only
available disease-modifying treatment option. The aim of this experts' perspective is to …

The present guideline (S2k) on allergen-specific immunotherapy (AIT) was established by
the German, Austrian and Swiss professional associations for allergy in consensus with the …

Background: Since the beginning of the COVID-19 pandemic, the treatment of patients with
allergic and atopy-associated diseases has faced major challenges. Recommendations for …

One hundred and ten years after Noon's first clinical report of the subcutaneous application
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …